You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Merck
Boehringer Ingelheim
Express Scripts
Colorcon

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

FLUDEOXYGLUCOSE F-18 - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for fludeoxyglucose f-18 and what is the scope of freedom to operate?

Fludeoxyglucose f-18 is the generic ingredient in one branded drug marketed by Downstate Clincl, 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens, Cardinal Health 414, Childrens Hosp Mi, Cpdc, Decatur, Essential Isotopes, Feinstein, Hot Shots Nm Llc, Jubilant Draximage, Kettering Medctr, Kreitchman Pet Ctr, Lantheus Medical, Ma General Hosp, Mcprf, Mem Sloan-kettering, Methodist Hosp Res, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Northland, Petnet, Precision Nuclear, Queen Hamamatsu Pet, Shertech Labs Llc, Sofie, Spectron Mrc Llc, Trustees Univ Pa, Ucla Biomedical, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Michigan, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Utah Cyclotron, Weill Medcl Coll, Wi Medcl Cyclotron, and Wusm Cyclotron, and is included in forty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for fludeoxyglucose f-18. Twenty-seven suppliers are listed for this compound.

Summary for FLUDEOXYGLUCOSE F-18
Pharmacology for FLUDEOXYGLUCOSE F-18

US Patents and Regulatory Information for FLUDEOXYGLUCOSE F-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biomedcl Res Fdn FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203837-001 May 1, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Spectron Mrc Llc FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203911-001 Apr 22, 2015 RX No No   Start Trial   Start Trial   Start Trial
Mips Crf FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 204472-001 Sep 11, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Ucsf Rodiopharm FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203902-001 May 9, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Merck
Boehringer Ingelheim
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.